New York, NY #2 in Cancer Overview Rankings Cancer Scorecard Cancer ratings are based on analysis of factors such as patient outcomes in the medical and surgical treatment of cancer, volume of high-risk patients, patient experience, nurse staffing, and advanced clinical technologies. Each hospital...
Pancreatic cancer is currently the third leading cause of cancer-related deaths in the United States and the fifth leading cause in Europe1,2, and is predicted to become the second leading cause of cancer-related deaths in the United States by 20303,4. Incidence rates of pancreatic cancer have...
Our experts at NYU Langone’s Perlmutter Cancer Center work together to carry out groundbreakingbasic and translational research. We have one of the largest portfolios ofclinical trials for pancreatic cancerin the country and are one of the few centers in the United States with multiple clinical tr...
doi:10.1200/JCO.2012.48.1887PubMedGoogle ScholarCrossref See More About Oncology Drug Development Regulatory Agencies Guidelines open access Trending Masking Policies at NCI–Designated Cancer Centers During Winter COVID-19 Surge Research July 31, 2024 Challenges of Surveillance in Implementing Nonoperative...
The FDA has deemed the Antigenics Inc. (New York, NY) Oncophage late-stage investigational cancer vaccine an orphan drug for metastatic melanoma. The FDA orphan drug designation was designed to encourage the development of therapies for conditions affecting fewer than 200,000 people in the United...
Second, this study enrolled patients across a small number of tertiary care cancer centers. To assess whether this introduced bias, we generated a synthetic control arm of patients receiving chemotherapy from PRINCE’s top enrolling sites who met this study’s inclusion and exclusion criteria and ...
These findings highlight a pressing need to increase engagement between Cancer Centers and their organizations regarding sustainability plans, and a need for greater transparency in publicizing sustainability plans.Ashray ManiarColumbia University Irving Medical Center, New York, NY;Katie Lichter...
Clifton Mountain of 5319 cases (4351 patients treated at the MD Anderson Cancer Center, and 968 from other North American centers), led to a revision of the stage classifications but maintained the existing distinctions among the N descriptors.34 In the absence of compelling alternative data, no...
All Centers provided ethical approval for this study and informed consent was obtained from all participants (NIB12-0034). This was a retrospective study, and the patients were recruited during 2005–2012. None of the patients had received any sort of ICI therapy prior to resection. At the ...
Weiser, MD, Colorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065 (weiser1@mskcc.org). Accepted for Publication: December 21, 2017. Published Online: March 22, 2018. doi:10.1001/jamaoncol.2018.0071...